Allspring Global Investments’s Niagen Bioscience NAGE Stock Holding History

Allspring Global Investments’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,855	Closed	-$83.2K	–	1975
2026 Q1	$83.2K	Buy	18,855 +1,940	+11%	+$10.5K	﹤0.01%	1654
2025 Q4	$108K	Buy	16,915 +1,478	+10%	+$10.3K	﹤0.01%	1612
2025 Q3	$144K	Sell	15,437 -153	-1%	-$1.54K	﹤0.01%	1570
2025 Q2	$225K	Buy	+15,590	New	+$154K	﹤0.01%	1527
2024 Q4	–	Sell	-1,746	Closed	-$6.37K	–	2473
2024 Q3	$6.37K	Buy	+1,746	New	+$5.5K	﹤0.01%	2144
2022 Q2	–	Sell	-74,166	Closed	-$182K	–	2974
2022 Q1	$182K	Sell	74,166 -5,398	-7%	-$14.7K	﹤0.01%	2596
2021 Q4	$297K	Buy	+79,564	New	+$430K	﹤0.01%	2516

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments's NAGE Position: Q2 2026 in Review

Allspring Global Investments sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 18,855 shares — an estimated $83.2K sold.

Allspring Global Investments first reported a position in NAGE in Q4 2021 and held it in 7 quarters. The position peaked at $297K in Q4 2021. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Allspring Global Investments reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
Allspring Global Investments sold 18,855 Niagen Bioscience shares in Q2 2026, an estimated $83.2K.
Allspring Global Investments first reported a position in Niagen Bioscience in Q4 2021 and held it in 7 quarters.
Allspring Global Investments's Niagen Bioscience position peaked at $297K in Q4 2021.
139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.